Why the stock of this potential Covid vaccine maker jumped nearly 456% this week

The South San Francisco company said Thursday that it signed a manufacturing memorandum of understanding, and today it said its vaccine would be part of an animal study sponsored by the federal government's Operation Warp Speed effort to bring a Covid-19 vaccine to market in January.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.